サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1792608

デジタル病理検査の市場規模、シェア、動向、予測：製品、タイプ、提供モデル、エンドユーザー、用途、地域別、2025～2033年

Digital Pathology Market Size, Share, Trends and Forecast by Product, Type, Delivery Model, End-User, Application, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
デジタル病理検査の市場規模、シェア、動向、予測：製品、タイプ、提供モデル、エンドユーザー、用途、地域別、2025～2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタル病理検査の世界市場規模は、2024年に10億2,214万米ドルとなりました。今後、2033年には23億2,006万米ドルに達すると予測され、2025～2033年のCAGRは8.54%です。現在、北米が市場を独占しており、2024年には40.7％を超える大きな市場シェアを占めています。この市場を牽引しているのは、世界の慢性疾患の蔓延が進む中、精度を高め、ワークフローを合理化する先進的診断ツールに対する需要が急増していることです。さらに、技術革新、ヘルスケアのデジタル化の進展、支持的な規制の枠組みが市場成長を促進し、デジタル病理検査の世界市場シェアをさらに拡大しています。

デジタル病理検査市場は、先進的診断ツールに対する需要の高まりと、がんなどの慢性疾患の罹患率の上昇によって牽引されています。人工知能と機械学習の統合は、診断精度を高め、病理医のワークフローを合理化します。例えば、ロシュは2024年9月、がん診断の向上を目指し、8つのパートナーから20以上のAIアルゴリズムを組み込んで、デジタル病理検査オープン環境を拡大しました。このイニシアチブは、正確な診断と個別化ヘルスケアのための先進技術により、標的治療を通じて患者の転帰を改善し、がん研究に革命をもたらす精密医療において臨床医を支援することを目的としています。ヘルスケアのデジタル化と遠隔病理検査ソリューションへの投資の拡大は、遠隔診察とセカンドオピニオンを可能にする市場導入をさらに後押しします。デジタルシステムに対する規制当局の承認や個別化医療へのシフトも重要な要因です。画像技術やクラウドベースデータストレージソリューションの進歩は、スケーラビリティをサポートし、アクセシビリティを向上させ、デジタル病理検査を現代のヘルスケアインフラの重要なコンポーネントにしています。

米国のデジタル病理検査市場は、精密医療への注目の高まりとヘルスケア技術の進歩によって牽引されています。画像分析に人工知能を採用することで、診断効率と精度が向上し、質の高い患者ケアに対する需要の高まりに対応しています。がんなどの慢性疾患の罹患率の上昇が、先進的病理学ソリューションの需要を牽引しています。米国国立がんラボが発表したデータによると、2024年には米国で新たに200万1,140人のがん患者が発生し、61万1,720人ががん関連で死亡すると予測されています。男性では前立腺がん、肺がん、大腸がんが診断の48％を占め、女性では乳がん、肺がん、大腸がんが51％を占めるといいます。がんの罹患率は人口10万人当たり440.5人で、死亡率は146人です。政府のイニシアティブと有利な規制の枠組みは、遠隔診察のための遠隔病理検査を含むデジタルプラットフォームの採用を加速させています。クラウドベースストレージソリューションの統合により、シームレスなデータ共有と拡大性が可能になる一方、ヘルスケアのデジタル化と調査への多額の投資が、国内での市場拡大をさらに後押ししています。

デジタル病理検査市場動向

技術の進歩

画像処理技術、ソフトウェア開発、統合機能における絶え間ない技術革新のペースは極めて重要です。強化された画像技術は正確な診断に不可欠な高解像度画像を提供する一方、人工知能（AI）と機械学習（ML）を活用した先進的アルゴリズムは診断精度を向上させ、面倒な作業を自動化し、予測分析を可能にします。報告によると、医療診断におけるAIは、健康アウトカムを40％改善し、治療費を50％削減する可能性があります。これらの進歩は、より迅速で正確な患者の診断と予後予測を容易にし、ひいては遠隔診察をサポートし、膨大なデータの保存と管理を可能にするため、このシステムの世界の普及を促進します。電子カルテ（EMR）や検査情報システム（LIS）との統合は、ワークフローを合理化し、臨床効率を高め、ヘルスケアへの協調的アプローチを促進し、デジタル病理検査市場の成長をさらに後押しします。主要参入企業としては、Proscia、PathAI、Ibex Medical Analytics、Paige、Clarapathなどが挙げられます。これらの参入企業は、これらの技術を発展させ、コラボレーティブなヘルスケアエコシステムを育成し、デジタル病理検査の世界の採用を加速させることに貢献しています。

慢性疾患の増加

がんなどの慢性疾患の世界の増加により、より効率的な診断ソリューションが求められており、現代ヘルスケアにおける重要なツールとして位置づけられています。米国国立医療図書館によると、慢性疾患の世界の増加は、2019年の全死亡の74%を占めており、2010年の67%から憂慮すべき増加であることが浮き彫りになっています。病理医がデジタルスライドを従来型顕微鏡検査よりも迅速かつ正確に分析・解釈できるようにすることで、診断プロセスを加速し、患者の転帰を改善します。先進的組織分析をサポートし、詳細な検査を可能にし、個別化医療や標的治療に不可欠な疾患マーカーの同定を支援します。大量の症例を管理する能力は、病理検査室における作業負荷の増大に効果的に対応し、効果的な疾病管理と治療計画に必要な迅速かつ正確な診断をサポートします。

遠隔病理検査の需要の高まり

特に世界の健康課題を背景に、遠隔診断の必要性はかつてないほど高まっています。遠隔病理診断が促進され、病理医が地理的な制約に関係なく高品質のデジタルスライドを検査・共有できるようになるため、病理診断サービスの中断がなくなります。これは、専門的なヘルスケアサービスへのアクセスが限られている地域にとって特に有利であり、診断精度を高める専門家によるコンサルテーションやセカンド・オピニオンを可能にします。遠隔病理検査は、地方と都市のヘルスケア施設間のギャップを埋め、質の高い医療サービスへのアクセスを民主化し、より協力的、効率的、効果的なヘルスケア・エコシステムを促進します。例えばWHOは、特に低・中所得国において、2030年までに1,000万人の医療従事者が不足すると予測しており、遠隔病理検査のような革新的なソリューションに対する需要を生み出しています。デジタルシステムの拡大性は、増加するスライド量への対応を可能にし、増大する診断需要に対応すると同時に、より統合された患者中心のヘルスケアソリューションを促進します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のデジタル病理検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • スキャナー
  • ソフトウェア
  • ストレージシステム
  • 通信システム

第7章 市場内訳：タイプ別

  • 人間病理学
  • 獣医病理学

第8章 市場内訳：提供モデル別

  • オンプレミス
  • ホスト

第9章 市場内訳：用途別

  • 研修と教育
  • コンサルティングサービス
  • 術中相談
  • 定期診断相談サービス
  • その他

第10章 市場内訳：エンドユーザー別

  • 製薬バイオテクノロジー企業
  • 病院と基準検査機関
  • 学術研究機関

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • その他
  • 中東・アフリカ
    • トルコ
    • サウジアラビア
    • イラン
    • アラブ首長国連邦
    • その他

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • DHISTECH
    • Apollo Enterprise Imaging
    • Corista
    • Hamamatsu Photonics
    • Huron Digital Pathology
    • Indica Labs
    • Koninklijke Philips
    • Leica Biosystems
    • Objective Pathology Services
    • Ventana Medical Systems
    • Visiopharm
    • XIFIN
図表

List of Figures

  • Figure 1: Global: Digital Pathology Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Pathology Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Digital Pathology Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Digital Pathology Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Digital Pathology Market: Breakup by Delivery Model (in %), 2024
  • Figure 6: Global: Digital Pathology Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Digital Pathology Market: Breakup by End-User (in %), 2024
  • Figure 8: Global: Digital Pathology Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Digital Pathology (Scanners) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Digital Pathology (Scanners) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Digital Pathology (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Digital Pathology (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Digital Pathology (Storage Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Digital Pathology (Storage Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Digital Pathology (Communication Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Digital Pathology (Communication Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Digital Pathology (Human Pathology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Digital Pathology (Human Pathology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Digital Pathology (Veterinary Pathology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Digital Pathology (Veterinary Pathology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Digital Pathology (On-premises) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Digital Pathology (On-premises) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Digital Pathology (Hosted) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Digital Pathology (Hosted) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Digital Pathology (Training and Education) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Digital Pathology (Training and Education) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Digital Pathology (Consulting Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Digital Pathology (Consulting Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Digital Pathology (Intraoperative Consultation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Digital Pathology (Intraoperative Consultation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Digital Pathology (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Digital Pathology (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Digital Pathology (Hospitals and Reference Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Digital Pathology (Hospitals and Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Digital Pathology (Academic & Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Digital Pathology (Academic & Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: North America: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: North America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: United States: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: United States: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Canada: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Canada: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Asia Pacific: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Asia Pacific: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: China: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: China: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Japan: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Japan: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: India: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: India: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: South Korea: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: South Korea: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Australia: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Australia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Indonesia: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Indonesia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Latin America: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Latin America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Brazil: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Brazil: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Mexico: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Mexico: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Argentina: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Argentina: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Colombia: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Colombia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Chile: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Chile: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Peru: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Peru: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Others: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Middle East and Africa: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Middle East and Africa: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Turkey: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Turkey: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Saudi Arabia: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 101: Saudi Arabia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 102: Iran: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 103: Iran: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 104: United Arab Emirates: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 105: United Arab Emirates: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 106: Others: Digital Pathology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 107: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 108: Global: Digital Pathology Industry: SWOT Analysis
  • Figure 109: Global: Digital Pathology Industry: Value Chain Analysis
  • Figure 110: Global: Digital Pathology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Pathology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Digital Pathology Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Digital Pathology Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Digital Pathology Market Forecast: Breakup by Delivery Model (in Million USD), 2025-2033
  • Table 5: Global: Digital Pathology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Digital Pathology Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 7: Global: Digital Pathology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Digital Pathology Market Structure
  • Table 9: Global: Digital Pathology Market: Key Players
目次
Product Code: SR112025A1836

The global digital pathology market size was valued at USD 1,022.14 Million in 2024. Looking forward, the market is projected to reach USD 2,320.06 Million by 2033, exhibiting a CAGR of 8.54% during 2025-2033. North America currently dominates the market, holding a significant market share of over 40.7% in 2024. The market is driven by the surging demand for advanced diagnostic tools that enhance accuracy and streamline workflows amid rising chronic disease prevalence worldwide. Additionally, technological breakthroughs, increased healthcare digitization and supportive regulatory frameworks propel market growth, further augmenting the global digital pathology market share.

The digital pathology market is driven by the rising demand for advanced diagnostic tools and the heightened incidence of chronic diseases such as cancer. The integration of artificial intelligence and machine learning enhances diagnostic accuracy and streamlining workflows for pathologists. For instance, in September 2024, Roche expanded its Digital Pathology Open Environment by incorporating more than 20 AI algorithms from eight partners, aimed at improving cancer diagnostics. This initiative aims to support clinicians in precision medicine improving patient outcomes through targeted treatments and revolutionizing cancer research with advanced technology for accurate diagnosis and personalized healthcare. Growing investments in healthcare digitization and telepathology solutions further boost market adoption enabling remote consultations and second opinions. Regulatory approvals for digital systems and the shift toward personalized medicine are also significant factors. Advancements in imaging technologies and cloud-based data storage solutions support scalability and improve accessibility making digital pathology a critical component of modern healthcare infrastructure.

The United States digital pathology market is driven by a rising focus on precision medicine and advancements in healthcare technologies. Increasing adoption of artificial intelligence for image analysis enhances diagnostic efficiency and accuracy meeting the growing demand for high-quality patient care. The rising incidence of chronic diseases, such as cancer, drives the demand for advanced pathology solutions. According to data published by the National Cancer Institute, in 2024, the U.S. is projected to have 2,001,140 new cancer cases and 611,720 cancer-related deaths. Prostate, lung and colorectal cancers will account for 48% of diagnoses in men while breast, lung and colorectal cancers will make up 51% in women. The cancer incidence rate is 440.5 per 100,000 people, with a mortality rate of 146.0. Government initiatives and favorable regulatory frameworks accelerate the adoption of digital platforms including telepathology for remote consultations. The integration of cloud-based storage solutions enables seamless data sharing and scalability while significant investments in healthcare digitization and research further support the market's expansion across the country.

Digital Pathology Market Trends:

Technological advancements

The relentless pace of innovation in imaging techniques, software development and integration capabilities has been pivotal. Enhanced imaging technologies offer high-resolution images essential for accurate diagnosis while sophisticated algorithms powered by artificial intelligence (AI) and machine learning (ML) improve diagnostic precision, automate tedious tasks and enable predictive analytics. According to reports, AI in medical diagnosis has the potential to improve health outcomes by 40% and lower treatment costs by 50%.These advancements facilitate faster and more accurate patient diagnoses and prognoses which in turn support remote consultations and enable vast data storage and management thus driving the adoption of this systems globally. The integration of this with electronic medical records (EMRs) and laboratory information systems (LIS) streamlines workflows, enhances clinical efficiency, and fosters a more collaborative approach to healthcare further propelling the digital pathology market growth. Some of the key players include Proscia, PathAI, Ibex Medical Analytics, Paige, and Clarapath, who have been instrumental in advancing these technologies, fostering collaborative healthcare ecosystems and accelerating the adoption of digital pathology globally.

Increasing prevalence of chronic diseases

The global increase in chronic illnesses such as cancer demands more efficient diagnostic solutions, positioning it as a crucial tool in modern healthcare. According to National Library of Medicine, the global rise in chronic illnesses, responsible for 74% of all deaths in 2019, highlights an alarming increase from 67% in 2010. It enables pathologists to analyze and interpret digital slides with greater speed and precision compared to traditional microscopy, thereby accelerating the diagnostic process and improving patient outcomes. It supports advanced tissue analysis, enabling detailed examination and aiding in the identification of disease markers, which is vital for personalized medicine and targeted therapies. Its capacity for managing large volumes of cases effectively addresses the growing workload in pathology labs, thereby supporting the rapid and accurate diagnosis necessary for effective disease management and treatment planning, making it indispensable in the fight against chronic diseases.

Growing demand for telepathology

The need for remote diagnostics has never been more pronounced, especially in the wake of global health challenges. It facilitates telepathology, allowing pathologists to examine and share high-quality digital slides irrespective of geographical constraints, thus ensuring uninterrupted pathology services. This is particularly advantageous for regions with limited access to specialized healthcare services, enabling expert consultation and second opinions that enhance diagnostic accuracy. Telepathology bridges the gap between rural and urban healthcare facilities, democratizing access to high-quality medical services and fostering a more collaborative, efficient, and effective healthcare ecosystem. For instance, WHO projects a shortage of 10 Million health workers by 2030, particularly in low- and lower-middle-income countries creating demand for innovative solution like telepathology. The scalability of digital systems allows for the handling of increasing slide volumes, catering to growing diagnostic demands while promoting more integrated and patient-centric healthcare solutions.

Digital Pathology Industry Segmentation:

Analysis by Product:

  • Scanners
  • Software
  • Storage Systems
  • Communication Systems

Scanners leads the market due to their critical role in digitizing histopathological slides for analysis, storage, and sharing. These devices range from high-throughput models designed for large laboratories to more compact versions for smaller settings, all aiming to deliver high-resolution images that retain the nuances of traditional microscopy. The advancement in scanning technologies has significantly reduced the time and cost per slide, enabling a seamless transition from analog to digital formats. This shift is instrumental in accommodating the growing volume of pathology samples, driven by an increase in cancer cases and other chronic diseases that necessitate detailed tissue analysis. Furthermore, the integration of scanners with AI and ML algorithms has facilitated new methods for automated image analysis, increasing diagnostic precision and effectiveness. As the cornerstone of this, scanners continue to improve, incorporating faster scanning speeds, higher image resolutions, and improved usability, ensuring their dominance in the market.

Analysis by Type:

  • Human Pathology
  • Veterinary Pathology

Human Pathology leads the market with around 62.2% of digital pathology market share in 2024. Human pathology plays a pivotal role in modern healthcare by enabling the detailed examination and analysis of human tissue samples. This segment has gained substantial momentum due to its crucial role in diagnosing a wide array of human diseases, especially cancer, where precision and timely diagnosis are vital. The integration of advanced imaging technologies, AI, and machine learning algorithms has significantly enhanced the accuracy, efficiency, and speed of pathological analysis, leading to improved patient outcomes. These technologies facilitate the detailed examination of slides, enabling pathologists to detect diseases at earlier stages and with greater precision. Furthermore, human pathology benefits immensely from digital archiving, which improves data retrieval and sharing, supporting collaborative diagnostics and research globally. The ability to quickly share high-resolution images across locations has also been instrumental in advancing telepathology, making specialized diagnostic expertise more accessible and facilitating second opinions, thereby enhancing the quality of care and patient management.

Analysis by Delivery Model:

  • On-premises
  • Hosted

The on-premises delivery model offers substantial control over the infrastructure and data, a critical factor for many healthcare organizations. This model involves the installation of software and hardware within the premises of the organization, ensuring robust data security and privacy, as it allows sensitive patient data to remain within the institution's firewall. It is particularly favored by large healthcare institutions and research facilities that prioritize data control, require high-speed access to large image files, and can afford the significant upfront investment in infrastructure. The on-premises model also facilitates compliance with stringent regulatory standards, as healthcare providers can directly oversee the management and security of the data.

Analysis by Application:

  • Training and Education
  • Consulting Services
  • Intraoperative Consultation
  • Routine Diagnostic Consultation Services
  • Others

Routine diagnostic consultation services represent the core application of this in everyday healthcare practices. This segment encompasses the use of this is for standard diagnostic evaluations, where pathologists review digitized slide images to detect, diagnose, and provide prognostic information on various diseases, primarily cancer. The integration of this in routine diagnostics significantly enhances the efficiency, accuracy, and speed of diagnostic processes. It allows for the storage of vast amounts of digital slides and associated data, facilitating easier data retrieval, long-term case study, and educational use. The technology's ability to enable quick sharing of digital slides and collaborative diagnostics also supports multi-disciplinary team meetings, ensuring comprehensive patient care.

Analysis by End-User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Academic and research institutes leads the market with around 45.7% of market share in 2024. Academic and research institutes represent the education, research, and diagnostic applications. The adoption of this in these institutes facilitates comprehensive educational programs, allowing students and trainees to access a wealth of digital slides and participate in interactive learning environments. It significantly enhances research capabilities, providing researchers with the tools to perform detailed morphological analyses, quantitative assessments, and high-throughput image analysis. This is crucial for advancing our understanding of disease pathology, developing novel therapeutic strategies, and contributing to the body of scientific knowledge.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

In 2024, North America accounted for the largest market share of over 40.7%. North America region boasts high-tech healthcare infrastructure, high adoption of digital imaging solutions, and significant investments in healthcare IT. The presence of prominent market players who consistently innovate in AI and machine learning technologies drives the dynamic growth of this sector. Furthermore, the region's strong emphasis on cancer research, coupled with substantial funding for oncology studies, propels the demand for this is to enable quick, accurate diagnoses and research applications. Regulatory support from bodies like the FDA, which has been progressively approving this system for diagnostic use, also plays a crucial role.. Additionally, the increasing shift towards personalized medicine in North America requires comprehensive tissue analyses, thereby driving the adoption of these solutions.

Key Regional Takeaways:

United States Digital Pathology Market Analysis

In 2024, United States accounted for a share of 89.80% of the North America market. In the United States the adoption of digital pathology is significantly influenced by the expansion of sophisticated healthcare systems. As healthcare infrastructure evolves with cutting-edge technologies such as advanced imaging and data analytics there is an increasing shift towards incorporating digital pathology for more efficient diagnostic processes. For instance, venture-capital investments in health AI in the United States are set to hit USD 11 Billion this year fuelling advancements in healthcare infrastructure. These developments are pivotal for enhancing digital pathology modifying diagnostic capabilities and workflow efficiency. The integration of high-performance computing, cloud-based systems and artificial intelligence further enhances the ability to store, analyze and share pathology data promoting collaboration and improving diagnostic accuracy. These developments foster an environment where healthcare providers can better manage and interpret vast volumes of patient data, driving faster and more precise diagnoses. Additionally, healthcare institutions are continuously expanding their capabilities with state-of-the-art equipment reinforcing the trend toward digital pathology as an essential tool for enhancing diagnostic workflows.

Asia Pacific Digital Pathology Market Analysis

In the Asia-Pacific region the ongoing digital transformation in the healthcare sector plays a pivotal role in the rise of digital pathology adoption. According to reports, 79% of innovations among Indian MedTech start-ups focus on medical technology solutions with 63% integrating digital advancements. This growing trend is particularly beneficial for Digital Pathology enhancing diagnostic precision and accessibility. Governments and private healthcare providers are increasingly focusing on incorporating digital tools aiming to streamline medical processes, reduce costs and improve the quality of care. As healthcare systems modernize and adopt more electronic health records, imaging technologies and telemedicine services the transition to digital pathology becomes more seamless. Moreover, the growing emphasis on healthcare accessibility and affordability encourages the integration of digital pathology solutions to bridge gaps in medical services especially in rural and underserved areas leading to better patient outcomes.

Europe Digital Pathology Market Analysis

In Europe, the growing prevalence of chronic illnesses is a key driver in the increased adoption of digital pathology. As the region faces a rising burden of conditions such as cancer, cardiovascular diseases and diabetes there is a significant demand for more precise and timely diagnostic tools. For instance, in the UK, 395,181 cancer cases were diagnosed in 2021 highlighting the increasing demand for advanced diagnostic tools. This growing trend is driving the adoption of digital pathology offering more efficient and accurate cancer detection. Digital pathology enables the use of advanced imaging techniques and data-driven insights allowing for more accurate detection and personalized treatment plans. With the need for improved diagnostic efficiency in managing chronic diseases healthcare providers are increasingly turning to digital pathology to enhance workflow, reduce errors and expedite diagnosis resulting in better management of these long-term health conditions.

Latin America Digital Pathology Market Analysis

In Latin America, the increasing availability of disposable income among the population is accelerating the adoption of digital pathology. For instance, total disposable income in Latin America is projected to grow by nearly 60% from 2021 to 2040 driven by regional equality, technological progress and sectoral shifts benefiting the expansion of digital healthcare services. As individuals in the region experience rising economic prosperity there is a greater ability to access advanced healthcare services including digital diagnostic tools. Healthcare institutions are upgrading their facilities to include digital pathology solutions offering enhanced precision and efficiency in diagnoses. This financial growth supports the widespread implementation of digital solutions in medical practices allowing patients to benefit from quicker more accurate diagnostic results and fostering a healthier population overall.

Middle East and Africa Digital Pathology Market Analysis

In the Middle East and Africa, the development of healthcare infrastructure is promoting the widespread adoption of digital pathology technologies . According to Dubai Healthcare City Authority report, by 2022, Dubai saw 4,482 private medical facilities including 56 hospitals and 55,208 licensed medical professionals. The projected 10-15% growth in medical professionals and 3-6% increase in facilities will enhance the adoption of digital pathology improving healthcare services and diagnostic capabilities. As healthcare infrastructure continues to grow in these regions particularly in urban areas there is an increasing integration of advanced diagnostic tools to meet the rising demand for high-quality medical care. With a focus on modernizing hospitals and medical centres there is greater investment in digital pathology systems that can enhance the speed, accuracy and collaboration in diagnosing a wide range of diseases. The improved access to state-of-the-art healthcare facilities makes digital pathology more accessible and increasingly prevalent benefiting both patients and healthcare providers.

Competitive Landscape:

The digital pathology market is marked by intense competition driven by technological advancements and the growing adoption of AI-powered diagnostic tools. Companies focus on enhancing image analysis, data integration and cloud-based solutions to streamline pathology workflows and improve diagnostic accuracy. The market sees strong collaboration between technology providers, healthcare institutions and research organizations to develop scalable and interoperable systems. For instance, in July 2024, AGFA HealthCare launched its integrated solution Enterprise Imaging for Pathology powered by Corista DP3 in North America. Designed by pathologists for pathologists it enhances digital workflow, efficiency, data management and collaboration addressing the transition from analog to digital pathology. Increasing demand for telepathology and remote consultation capabilities further fuels innovation. Regulatory approvals and conformity with healthcare standards play a key role in enabling market players to obtain a competitive advantage.. The push for personalized medicine and improved patient outcomes motivates continuous research and development positioning digital pathology as a vital component in modern diagnostics and healthcare infrastructure.

The report provides a comprehensive analysis of the competitive landscape in the digital pathology market with detailed profiles of all major companies, including:

  • DHISTECH
  • Apollo Enterprise Imaging
  • Corista
  • Hamamatsu Photonics
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips
  • Leica Biosystems
  • Objective Pathology Services
  • Ventana Medical Systems
  • Visiopharm
  • XIFIN

Key Questions Answered in This Report

  • 1.How big is the global digital pathology market?
  • 2.What is the expected growth rate of the global digital pathology market during 2025-2033?
  • 3.What are the key factors driving the global digital pathology market?
  • 4.What is the leading segment of the global digital pathology market based on product?
  • 5.Who are the key players/companies in the global digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Pathology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Scanners
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Storage Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Communication Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Human Pathology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Veterinary Pathology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Delivery Model

  • 8.1 On-premises
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hosted
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Training and Education
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Consulting Services
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Intraoperative Consultation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Routine Diagnostic Consultation Services
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Pharmaceutical & Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Reference Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Italy
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Russia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 Japan
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 India
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Indonesia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Colombia
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
    • 11.4.5 Chile
      • 11.4.5.1 Market Trends
      • 11.4.5.2 Market Forecast
    • 11.4.6 Peru
      • 11.4.6.1 Market Trends
      • 11.4.6.2 Market Forecast
    • 11.4.7 Others
      • 11.4.7.1 Market Trends
      • 11.4.7.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 Iran
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 United Arab Emirates
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast
    • 11.5.5 Others
      • 11.5.5.1 Market Trends
      • 11.5.5.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 DHISTECH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Apollo Enterprise Imaging
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Corista
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Hamamatsu Photonics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Huron Digital Pathology
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indica Labs
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Koninklijke Philips
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Leica Biosystems
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Objective Pathology Services
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ventana Medical Systems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Visiopharm
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 XIFIN
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio